Literature DB >> 21493366

Pathways analysis of molecular markers in chronic sinusitis with polyps.

Michael P Platt1, Zachary Soler, Ralph Metson, Konstantina M Stankovic.   

Abstract

OBJECTIVE: To perform a comprehensive molecular pathways analysis of genes identified through genome-wide expression profiling and the published literature for chronic sinusitis with polyps. STUDY
DESIGN: Molecular pathways analysis.
SETTING: Academic medical center.
METHODS: A molecular pathways analysis of gene biomarkers discovered through hypothesis-driven and high-throughput molecular studies was performed. Genes identified with a PubMed literature search were analyzed with Ingenuity Pathways Analysis software to identify central molecules implicated in the pathogenesis of chronic sinusitis with polyps. The central pathways were then compared with those identified through genome-wide expression profiling of ethmoid polyps.
RESULTS: A total of 97 molecules were investigated with Ingenuity Pathways Analysis based on 55 studies that evaluated differences in gene expression (39), genetic variation (12), or proteomics (4). The analysis revealed 9 statistically significant molecular networks containing central nodes that included transcription factors, protein kinases, cytokines, and growth factors/receptors. The highest scoring networks implicated nuclear factor kappa-B, tumor necrosis factor, and mitogen-activated protein kinases. The majority of pathways in the literature review analysis overlapped with those identified through a single genome-wide expression study.
CONCLUSIONS: Chronic sinusitis with polyps is a complex disease with suspected contribution of multiple genetic and environmental factors. The search for causative genes has led to the discovery of numerous candidates. Pathways analysis applied to these candidate genes identified common central molecules that are likely to be key mediators of the disease process. Novel therapies targeting these molecules may be applicable for the treatment of chronic sinusitis with polyps.

Entities:  

Mesh:

Year:  2011        PMID: 21493366      PMCID: PMC4164309          DOI: 10.1177/0194599810395091

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  24 in total

1.  Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis.

Authors:  V Raia; L Maiuri; C Ciacci; I Ricciardelli; L Vacca; S Auricchio; M Cimmino; M Cavaliere; M Nardone; A Cesaro; J Malcolm; S Quaratino; M Londei
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

Review 2.  Epidemiology of nasal polyps.

Authors:  G A Settipane
Journal:  Allergy Asthma Proc       Date:  1996 Sep-Oct       Impact factor: 2.587

3.  A correlative study of NF-kappaB activity and cytokines expression in human chronic nasal sinusitis.

Authors:  R Xu; G Xu; J Shi; W Wen
Journal:  J Laryngol Otol       Date:  2006-10-11       Impact factor: 1.469

Review 4.  Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease.

Authors:  K F Chung; J A Marwick
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

5.  Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis.

Authors:  F C P Valera; R Queiroz; C Scrideli; L G Tone; W T Anselmo-Lima
Journal:  Clin Exp Allergy       Date:  2008-04       Impact factor: 5.018

Review 6.  The role of cytokines in chronic rhinosinusitis with nasal polyps.

Authors:  Bradley A Otto; Sally E Wenzel
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2008-06       Impact factor: 2.064

Review 7.  Kinase inhibitors and airway inflammation.

Authors:  Ian M Adcock; K Fan Chung; Gaetano Caramori; Kazuhiro Ito
Journal:  Eur J Pharmacol       Date:  2006-02-08       Impact factor: 4.432

8.  Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase.

Authors:  Sze-Kwan Lin; Sang-Heng Kok; Chia-Tung Shun; Chi-Yuan Hong; Chih-Chiang Wang; Ming-Che Hsu; Chia-Ming Liu
Journal:  Am J Rhinol       Date:  2007 Mar-Apr

9.  Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma.

Authors:  Konstantina M Stankovic; Hernan Goldsztein; Douglas D Reh; Michael P Platt; Ralph Metson
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

Review 10.  Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.

Authors:  Michael R Edwards; Nathan W Bartlett; Deborah Clarke; Mark Birrell; Maria Belvisi; Sebastian L Johnston
Journal:  Pharmacol Ther       Date:  2008-10-06       Impact factor: 12.310

View more
  5 in total

Review 1.  Therapy of Sinonasal Microbiome in CRS: A Critical Approach.

Authors:  Alkis J Psaltis; Peter-John Wormald
Journal:  Curr Allergy Asthma Rep       Date:  2017-09       Impact factor: 4.806

2.  One airway: Biomarkers of protection from upper and lower airway injury after World Trade Center exposure.

Authors:  Soo Jung Cho; Ghislaine C Echevarria; Sophia Kwon; Bushra Naveed; Edward J Schenck; Jun Tsukiji; William N Rom; David J Prezant; Anna Nolan; Michael D Weiden
Journal:  Respir Med       Date:  2013-11-13       Impact factor: 3.415

Review 3.  Role of innate immunity in the pathogenesis of chronic rhinosinusitis: progress and new avenues.

Authors:  Cornelis M van Drunen; Jenny M Mjösberg; Christine L Segboer; Marjolein E Cornet; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 4.  The microbiome and chronic rhinosinusitis.

Authors:  Rahuram Sivasubramaniam; Richard Douglas
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2018-10-31

Review 5.  Review: The Nose as a Route for Therapy. Part 2 Immunotherapy.

Authors:  Yorissa Padayachee; Sabine Flicker; Sophia Linton; John Cafferkey; Onn Min Kon; Sebastian L Johnston; Anne K Ellis; Martin Desrosiers; Paul Turner; Rudolf Valenta; Glenis Kathleen Scadding
Journal:  Front Allergy       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.